Sfrowasa
Product Images NDC 0037-0022

7 FDA label images from Viatris Specialty Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sfrowasa (NDC 0037-0022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viatris Specialty Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Image 01
Packaging label for sfRowasa Sulfite-Free Formulation Rectal Suspension, 4g/60mL (mesalamine) by Viatris Specialty LLC. The package is a 7 pack of 60 mL unit-dose bottles. The label emphasizes rectal use only, Rx only, and includes storage instructions along with a note to shake well before using. Distributed by Meda Pharmaceuticals.*
FDA Label Image

Mesalamine Chemical Structure (Sfrowasa 01)

Mesalamine Chemical Structure (Sfrowasa 01)
Chemical structure of the active ingredient in sfRowasa Sulfite-Free Formulation, depicting a benzene ring with amino, hydroxyl, and carboxyl functional groups attached.*
FDA Label Image

Step 1.a. (Sfrowasa 02)

Step 1.a. (Sfrowasa 02)
An instructional diagram showing two hands holding a rectangular packet with scissors cutting along a seam. The illustration is labeled with the instruction 'Grasp seam and tear down,' indicating how to open the packet for sfRowasa Sulfite-Free Formulation by Viatris Specialty LLC.*
FDA Label Image

Step 2.b. (Sfrowasa 03)

Step 2.b. (Sfrowasa 03)
An illustration showing two hands demonstrating the handling of a medical applicator device. The left hand holds a syringe-like tube upright, while the right hand holds an applicator tip, suggesting assembly or preparation for use.*
FDA Label Image

Step 3.a. (Sfrowasa 04)

Step 3.a. (Sfrowasa 04)
Illustration showing a person lying on their left side with knees bent toward the chest, commonly used to demonstrate a positioning method for rectal medication administration.*
FDA Label Image

Step 3.b. (Sfrowasa 05)

Step 3.b. (Sfrowasa 05)
An illustration showing a person in a kneeling position with their arms and head resting on the ground and their buttocks elevated. This position appears to demonstrate a posture or technique likely related to the use or administration of a medical product.*
FDA Label Image

Step 4.b. (Sfrowasa 06)

Step 4.b. (Sfrowasa 06)
An instructional line drawing depicting a hand holding and squeezing a rectal applicator. The image shows the correct positioning and grasp for administering sfRowasa Sulfite-Free Formulation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.